Value chain stagesInput

Products 91 to 100 of 120

Biotech components: Bacteria
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:34 (1 year ago)
Date last modified: 2020/12/18 14:34 (1 year ago)
Known funding amount: 3,200,000
Funding types: Foundation + Private Funding
Industry: Industrial + Multipurpose + Novelty
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction + Design + Other
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input + Platform
Pomecin by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/02 15:44 (4 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Porcupine (synthetic DNA tagging system) by University of Washington
Biotech components: Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:51 (1 year ago)
Date last modified: 2020/12/18 14:51 (1 year ago)
Known funding amount: N/A
Funding types: University
Industry: Multipurpose + Novelty
Market status: Early Stage Concept
Organization type(s): University
Product categories: Other
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Input + Platform
Probiotic Strains by Unibome + Peer to Peer Probiotics
Biotech components: Probiotic
Business models: B2B
Country of production: France
Country of distribution: France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Additive
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: North America + Africa + Europe + Asia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/02 06:17 (4 years ago)
Known funding amount: 8,946 USD
Funding types: Crowdfunding
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Public Funding + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Resveratrol by Evolva
Biotech components: Microbe
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Food + Personal Care (Topical) + Personal Care (Ingested)
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
rHuPH20 by Halozyme
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/01 09:37 (4 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Input
RNA-based Biocontrols by Syngenta
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/02 11:25 (4 years ago)
Known funding amount: 2,147,483,647 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: NASEM Database
Trading symbol: SYT (NYSE)
Value chain stage: Input
Sabacic Acid by Verdezyne
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/11/08 14:47 (4 years ago)
Known funding amount: 86,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Private Company
Product categories: Fiber
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input